Sidley-Led Roche To Buy US Pharma Biz For $3.5B
Swiss pharmaceutical behemoth Roche Holding AG said Thursday that it has agreed to acquire U.S.-based clinical-stage biopharmaceutical company 89bio Inc. for up to approximately $3.5 billion to boost its portfolio in...To view the full article, register now.
Already a subscriber? Click here to view full article